Lyell Immunopharma, Inc. earnings per share and revenue

LYEL earnings per share for the last quarter are -0.18 USD whereas the estimation was -0.20 USD which accounts for 8.86% surprise. Company revenue for the same period amounts to 13.00 k USD despite the estimated figure of 3.25 k USD. Estimated earnings per share for the next quarter are -0.20 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of LYEL earnings per share and revenue dynamics.